Comprehensive Online Oncology Database
New Medicine Oncology KnowledgeBASE
NEWS
SUBSCRIBER SEARCH
(Requires Login)
NEW DRUG
MARKETED DRUG
COMPANY
TARGETS IN ONCOLOGY
NEWS AND WEBCAST SUMMARIES
COMBINATION TRIALS
  
   1-949-830-0448   info@newmedinc.com   
 
ABOUT nm|OK
nm|OK FREE ACCESS AND DEMO
APPLICATIONS
DESCRIPTION OF MODULES
INQUIRIES AND FEEDBACK
LICENSE AGREEMENT
PRIVACY POLICY
SAMPLE QUERY SCREENS
SAMPLE REPORTS & RECORDS
SOURCES
SUBSCRIPTION INFORMATION
USER GUIDE

PRODUCTS AND SERVICES
FUTURE ONCOLOGY
FEATURED IN-DEPTH REPORTS
CUSTOM REPORT REQUEST

NEWS
NEWS SUMMARIES
LATEST nm|OK UPDATES
nm|OK NEWS RELEASES

SITE MAP
Having trouble finding something?
Use our site map.
 

Latest Updates
August 2008 New Drug Updates and Additions

Brand Name
Generic Name
Other Designation
  Masitinib mesylate AB1010
Xinlay Atrasentan ABT-627 (formerly A-147627)
     
     
    AB-1001
Anyara Naptumomab estafenatox ABR-217620, TTS CD3
Lovaxin C    
Hematide    
Onconase Ranpirnase Formerly P-30 protein
Alpharadin    
    ATL-104
  Goserelin  
    AG-003, AGS-003
  Deforolimus AP23573, MK-8669
    YM155
Zactima Vandetanib ZD6474, AZD6474, AZD-6474
    AZD6244, ARRY-142886, ARRY-886
    ATN-161
    ATN-224
    AVN-944, AVN944 (formerly VX-944)
    BP-100-1.01, L-Grb2
    BP-100-1.02
Doxorubicin Transdrug Doxorubicin  
Urocidin   Mycobacterial Cell Wall-DNA Complex (MCC), MCC/HA
    CPX-1
  Cytarabine:daunorubicin CPX-351
    CPX-571
Actimid Pomalidomide CC-4047
    CG0070
Opaxio (formerly Xyotax and PG-TXL) Paclitaxel poliglumex CT-2103
    CTCE-9908
    CR011, CR011-vcMMAE
    CUDC-101
  Seliciclib CYC200, CYC202
Immunodrugs   QbG10, CYT003-QbG10, CYT004-MelQbG10
Tumor-Selective Prodrug (TSP)    
    DTS-108
Egalet Morphine    
Egalet Hydrocodone    
Egalet Oxycodone    
Egalet Hydromorphone    
    EM101, LY303511 (LY3)
    EZN-2285
    PEG-SN38, EZN-2208
    EPC2407 (formerly MX2407 and MX116407)
     
    EP128265, MPI-0441138
StemEX    
VitiGam   GCAN 101, GCAN101
    PRO1762, TRAIL/Apo2L, Apo2L/TRAIL, AMG 951, rhApo2L
Omnitarg Pertuzumab R1273, 2C4, rhuMAb-2C4
HhAntag   Cur-691, GDC-0449
  Dacetuzumab SGN-40, SGN40 (anti-huCD40 MAb), huS2C6
Azintrel   OP-R003, anti-IL6
Orplatna Satraplatin JM-216 (formerly BMS-182751)
Mepact (Europe), formerly Junovan (USA) Mifamurtide Liposomal muramyl tripeptide phosphatidyl ethanolamine (L-MTP-PE), formerly CGP-19835A
    EP-2101, IDM-2101
    DXL625
    IMD 026260
    GTI 2040, GTI-2040, LOR-2040
    LOR-253, ML-220, ML-series (ML-133 and LT-253)
    CPI-0004, DTS-101, Super-Leu-Dox, DTS-201, CPI-004 Na
Ostarine   GTx-024
IMOxine   HYB2055, IMO-2055
    MLN4924
    MOR 202, MOR202
    EZN-2232
    NVX-207
    NVX-188
    HSpE7
    OGX-225 (OGX-225-5 and OGX-225-2)
    OGX-427
    SN2310
    CSP-9222
Reolysin (formerly Reosyn)    
    Oxi 4503, Oxi-4503, OXi4503, CA1P, CA-1-P
  Elotuzumab HuLuc63
    SU6668, SU-6668, SU006668, TSU-68 (Japan) TSU68
    CP-868,596, CP-868596
    PCI-27483
    PCI-34051
    PLX-1, PLXI, PLX-BMT
  Polyphenon E  
    INOC005
OncoGel Paclitaxel DTS-301
Acadra Acadesine  
Prolarix Tretazicar  
Provecta   PV-10
VelociSuite, VelocImmune    
    RP101, INOC001
    R1530
    EM-164 (murine), AVE1642 (human)
    eIF5A1, eIF-5A, factor 5A1 (F5A1), factor 5A
Vactocell    
    Atu027
  Elesclomol STA-4783, STA4783
Telcyta Canfosfamide HCl TLK286, TLK-286, (formerly TER286)
Telintra Ezatiostat HCl TLK199, TLK-199, formerly TER199
     
    TLK58747
     
    TRU-016, CytoxB37G, CD37SMIP
  Inotuzumab ozogamicin CMC-544, CMC544
    BVX-20
    VX15
Lenocta Sodium stibogluconate (SSG) VQD001, VQD-001
    TRU-015, CytoxB20G
Clearazide Meclorethamine  
    cis-ACCP
  Indibulin D-24851, ZIO-301
  Darinaparsin ZIO-101


HOME   |   NEW MEDICINE   |   SITE MAP

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM